Showing 17,481 - 17,500 results of 105,667 for search '(( 5 ((ng decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (mean decrease)) ))', query time: 1.10s Refine Results
  1. 17481
  2. 17482

    Table_2_v1_Distal end of Double-J ureteral stent position on ureteral stent-related symptoms: A systematic review and meta-analysis.docx by Xingjun Bao (12281198)

    Published 2022
    “…As for IPSS, although no significant differences in IPSS total (MD, 2.65; 95% CI, −0.24 to 5.54; P = 0.07) or voiding symptoms (MD, −0.84; 95% CI, −3.16 to 1.48; P = 0.48) scores were found, ipsilateral group was associated with a significant decrease in storage symptoms (MD, 1.92; 95% CI, 0.91 to 2.93; P = 0.0002). …”
  3. 17483

    Original data. by Yaotian Fan (5917766)

    Published 2025
    “…Person-Vocation Fit (P-V Fit) may play a key role in preventing burnout. …”
  4. 17484
  5. 17485
  6. 17486
  7. 17487
  8. 17488
  9. 17489

    Regioselective Ring Expansion of 3‑Ylideneoxindoles with Tosyldiazomethane (TsDAM): A Metal-Free and Greener Approach for the Synthesis of Pyrazolo-[1,5‑<i>c</i>]quinazolines by Gopathi Ramu (5805032)

    Published 2020
    “…The method is also compatible with a large variety of functional groups, providing good to excellent yields in water, thus resulting in a decrease of environmental impact in the pharmaceutical industry.…”
  10. 17490
  11. 17491
  12. 17492
  13. 17493
  14. 17494
  15. 17495

    Table 5_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.pdf by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  16. 17496

    Data_Sheet_2_Combined 5-Fluorouracil and Low Molecular Weight Heparin for the Prevention of Postoperative Proliferative Vitreoretinopathy in Patients With Retinal Detachment: A Met... by Chen Chen (6544)

    Published 2021
    “…</p><p>Results: Six clinical trials with a total of 1,208 participants were included. We found that combined 5-FU and LMWH infusion did not improve the primary success of vitrectomy at 6 months (RR = 1.00, 95% CI = 0.95, 1.07, P = 0.89, I<sup>2</sup> = 50%). …”
  17. 17497

    Data_Sheet_1_Combined 5-Fluorouracil and Low Molecular Weight Heparin for the Prevention of Postoperative Proliferative Vitreoretinopathy in Patients With Retinal Detachment: A Met... by Chen Chen (6544)

    Published 2021
    “…</p><p>Results: Six clinical trials with a total of 1,208 participants were included. We found that combined 5-FU and LMWH infusion did not improve the primary success of vitrectomy at 6 months (RR = 1.00, 95% CI = 0.95, 1.07, P = 0.89, I<sup>2</sup> = 50%). …”
  18. 17498

    Data_Sheet_4_Combined 5-Fluorouracil and Low Molecular Weight Heparin for the Prevention of Postoperative Proliferative Vitreoretinopathy in Patients With Retinal Detachment: A Met... by Chen Chen (6544)

    Published 2021
    “…</p><p>Results: Six clinical trials with a total of 1,208 participants were included. We found that combined 5-FU and LMWH infusion did not improve the primary success of vitrectomy at 6 months (RR = 1.00, 95% CI = 0.95, 1.07, P = 0.89, I<sup>2</sup> = 50%). …”
  19. 17499

    Data_Sheet_3_Combined 5-Fluorouracil and Low Molecular Weight Heparin for the Prevention of Postoperative Proliferative Vitreoretinopathy in Patients With Retinal Detachment: A Met... by Chen Chen (6544)

    Published 2021
    “…</p><p>Results: Six clinical trials with a total of 1,208 participants were included. We found that combined 5-FU and LMWH infusion did not improve the primary success of vitrectomy at 6 months (RR = 1.00, 95% CI = 0.95, 1.07, P = 0.89, I<sup>2</sup> = 50%). …”
  20. 17500